| 1 |
33675613 | The selective serotonin reuptake inhibitors enhance the cytotoxicity of sorafenib in hepatocellular carcinoma cells. | 2021 Sep 1 |
1 |
| 2 |
32547320 | AKR1B10 Inhibitor Epalrestat Facilitates Sorafenib-Induced Apoptosis and Autophagy Via Targeting the mTOR Pathway in Hepatocellular Carcinoma. | 2020 |
1 |
| 3 |
29932973 | Combinatorial treatment of Rhizoma Paridis saponins and sorafenib overcomes the intolerance of sorafenib. | 2018 Oct |
1 |
| 4 |
28903416 | Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade. | 2017 Aug 15 |
1 |
| 5 |
25952930 | The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma. | 2015 May 8 |
2 |
| 6 |
25953027 | Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer. | 2015 May 8 |
2 |
| 7 |
23434734 | The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models. | 2013 Apr 15 |
2 |
| 8 |
22753710 | The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment. | 2012 Jul |
3 |